Your browser doesn't support javascript.
loading
Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort study.
Dijksterhuis, Willemieke P M; Verhoeven, Rob H A; Meijer, Sybren L; Slingerland, Marije; Haj Mohammad, Nadia; de Vos-Geelen, Judith; Beerepoot, Laurens V; van Voorthuizen, Theo; Creemers, Geert-Jan; van Oijen, Martijn G H; van Laarhoven, Hanneke W M.
Afiliação
  • Dijksterhuis WPM; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
  • Verhoeven RHA; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
  • Meijer SL; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
  • Slingerland M; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Haj Mohammad N; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • de Vos-Geelen J; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Beerepoot LV; Department of Internal Medicine, Division of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht UMC+, Maastricht, The Netherlands.
  • van Voorthuizen T; Department of Medical Oncology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.
  • Creemers GJ; Department of Medical Oncology, Rijnstate Hospital, Arnhem, The Netherlands.
  • van Oijen MGH; Department of Medical Oncology, Catharina Hospital, Eindhoven, The Netherlands.
  • van Laarhoven HWM; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Gastric Cancer ; 23(4): 579-590, 2020 07.
Article em En | MEDLINE | ID: mdl-31927675

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Receptor ErbB-2 / Junção Esofagogástrica / Trastuzumab / Antineoplásicos Imunológicos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Gastric Cancer Assunto da revista: GASTROENTEROLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Receptor ErbB-2 / Junção Esofagogástrica / Trastuzumab / Antineoplásicos Imunológicos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Gastric Cancer Assunto da revista: GASTROENTEROLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda